Data / Drug companies / Promethazine hydrochloride and codeine phosphate
Promethazine hydrochloride and codeine phosphate: 5 companies and 5 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Promethazine hydrochloride and codeine phosphate is listed in the FDA National Drug Code Directory by 5 companies, with 5 products in commercial distribution. 5 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution, and the newest product started marketing on December 19, 2025.
The request: Get every company that lists promethazine hydrochloride and codeine phosphate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 5
- Products
- 5
- Generic (ANDA) products
- 5 (100.0%)
- Application numbers
- 2
- Controlled substance schedule
- Schedule V
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list promethazine hydrochloride and codeine phosphate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | March 12, 2018 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | March 12, 2018 |
| Cosette Pharmaceuticals, Inc. | 1 | solution | Generic drugs (ANDA) | December 19, 2025 |
| Cranbury Pharmaceuticals, LLC | 1 | solution | Generic drugs (ANDA) | March 12, 2018 |
| Quagen Pharmaceuticals LLC | 1 | solution | Generic drugs (ANDA) | October 8, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 5 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 5 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Opioid Agonist | 5 |
| Phenothiazine | 5 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.